Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Knapp

Showing results (431-440 of 451) with videos related to

Pageof 46
Sort By:
International Journal of Geriatric Psychiatry|October 15, 2016
Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)Martin Knapp, Derek King, Renée Romeo, et al.
Alzheimer Disease and Associated Disorders|February 26, 2019
A Comprehensive Model of Factors Associated With Capability to "Live Well" for Family Caregivers of People Living With Mild-to-Moderate Dementia: Findings From the IDEAL StudyLinda Clare, Yu-Tzu Wu, Catherine Quinn, et al.
Alzheimer Disease and Associated Disorders|February 26, 2019
A Comprehensive Model of Factors Associated With Subjective Perceptions of "Living Well" With Dementia: Findings From the IDEAL StudyLinda Clare, Yu-Tzu Wu, Ian R Jones, et al.
The Lancet. Neurology|October 31, 2015
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analysesRobert Howard, Rupert McShane, James Lindesay, et al.
The International Journal of Neuropsychopharmacology|March 8, 2008
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidenceNorman Sartorius, Thomas C Baghai, David S Baldwin, et al.
International Journal of Geriatric Psychiatry|September 18, 2010
Determining the minimum clinically important differences for outcomes in the DOMINO trialRobert Howard, Patrick Phillips, Tony Johnson, et al.
Age and Ageing|January 25, 2021
The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trialRobert Howard, Rebecca Gathercole, Rosie Bradley, et al.
Lancet (London, England)|February 18, 2022
Time for united action on depression: a Lancet-World Psychiatric Association CommissionHelen Herrman, Vikram Patel, Christian Kieling, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 12, 2020
The impact of assistive technology on burden and psychological well-being in informal caregivers of people with dementia (ATTILA Study)Anna Davies, Stefano Brini, Shashivadan Hirani, et al.
Dementia (London, England)|July 1, 2021
Beyond the project: Building a strategic theory of change to address dementia care, treatment and support gaps across seven middle-income countriesErica Breuer, Adelina Comas-Herrera, Emily Freeman, et al.
Pageof 46

Showing results (431-440 of 451) with videos related to

Sort By:
Pageof 46
International Journal of Geriatric Psychiatry|October 15, 2016
Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)Martin Knapp, Derek King, Renée Romeo, et al.
Alzheimer Disease and Associated Disorders|February 26, 2019
A Comprehensive Model of Factors Associated With Capability to "Live Well" for Family Caregivers of People Living With Mild-to-Moderate Dementia: Findings From the IDEAL StudyLinda Clare, Yu-Tzu Wu, Catherine Quinn, et al.
Alzheimer Disease and Associated Disorders|February 26, 2019
A Comprehensive Model of Factors Associated With Subjective Perceptions of "Living Well" With Dementia: Findings From the IDEAL StudyLinda Clare, Yu-Tzu Wu, Ian R Jones, et al.
The Lancet. Neurology|October 31, 2015
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analysesRobert Howard, Rupert McShane, James Lindesay, et al.
The International Journal of Neuropsychopharmacology|March 8, 2008
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidenceNorman Sartorius, Thomas C Baghai, David S Baldwin, et al.
International Journal of Geriatric Psychiatry|September 18, 2010
Determining the minimum clinically important differences for outcomes in the DOMINO trialRobert Howard, Patrick Phillips, Tony Johnson, et al.
Age and Ageing|January 25, 2021
The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trialRobert Howard, Rebecca Gathercole, Rosie Bradley, et al.
Lancet (London, England)|February 18, 2022
Time for united action on depression: a Lancet-World Psychiatric Association CommissionHelen Herrman, Vikram Patel, Christian Kieling, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 12, 2020
The impact of assistive technology on burden and psychological well-being in informal caregivers of people with dementia (ATTILA Study)Anna Davies, Stefano Brini, Shashivadan Hirani, et al.
Dementia (London, England)|July 1, 2021
Beyond the project: Building a strategic theory of change to address dementia care, treatment and support gaps across seven middle-income countriesErica Breuer, Adelina Comas-Herrera, Emily Freeman, et al.
Pageof 46